Life Sciences
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.
The company will use the funds to expand access to its AI-powered offering and improve operational efficiencies.
Yosi Health will join Elation's marketplace that connects primary care practices with technology platforms.
The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.
The company will use the funds to invest in companies that focus on the physical, mental, spiritual and social needs of senior adults.
Hippocratic AI's generative AI healthcare agents will be deployed across United Arab Emirates-based Burjeel Holding's healthcare network.
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
Podimetrics' SmartMat technology that helps diabetes patients manage foot health and mobility will be incorporated into HealthMed's employee-focused portfolio of benefits.
The partnership aims to ensure a steady supply of rare injectable drugs and streamline the procurement process.
Data from the clinical trial might give patients a new option for treating migraines.